Cargando…
Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
Background: Accumulating evidence indicates tumor-promoting roles of synaptotagmin 13 (SYT13) in several cancers; however, no studies have investigated its expression in breast cancer (BC). This study aimed to clarify the significance of SYT13 in BC. Methods: SYT13 mRNA expression levels were evalua...
Autores principales: | Ichikawa, Takahiro, Shibata, Masahiro, Inaishi, Takahiro, Soeda, Ikumi, Kanda, Mitsuro, Hayashi, Masamichi, Takano, Yuko, Takeuchi, Dai, Tsunoda, Nobuyuki, Kodera, Yasuhiro, Kikumori, Toyone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535095/ https://www.ncbi.nlm.nih.gov/pubmed/34677264 http://dx.doi.org/10.3390/curroncol28050346 |
Ejemplares similares
-
MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer
por: Watanabe, Manabu, et al.
Publicado: (2020) -
Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy
por: Inaishi, Takahiro, et al.
Publicado: (2018) -
Postoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence
por: Adachi, Yayoi, et al.
Publicado: (2015) -
Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
por: Shibata, Masahiro, et al.
Publicado: (2017) -
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
por: Miyajima, Noriyuki, et al.
Publicado: (2021)